CCDR: Volume 48-9, September 2022: Invasive Diseases Surveillance in Canada

Table of contents

Rapid Communication
Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2022–2023
A Sinilaite, J Papenburg on behalf of the National Advisory Committee on Immunization (NACI)

Summary of the National Advisory Committee on Immunization (NACI) Supplemental Statement on Recombinant Influenza Vaccines
A Gil, A Sinilaite, J Papenburg on behalf of the National Advisory Committee on Immunization (NACI)

Evaluation of influenza case definitions for use in real-world evidence research
P Doyon-Plourde, É Fortin, C Quach

Surveillance
Invasive pneumococcal disease surveillance in Canada, 2020
A Golden, A Griffith, W Demczuk, B Lefebvre, A McGeer, G Tyrrell, G Zhanel, J Kus, L Hoang, J Minion, P Van Caeseele, H Smadi, D Haldane, G Zahariadis, K Mead, L Steven, L Strudwick, A Li, M Mulvey, I Martin

Invasive group A streptococcal disease surveillance in Canada, 2020
A Golden, A Griffith, W Demczuk, G Tyrrell, J Kus, A McGeer, M-C Domingo, L Hoang, J Minion, P Van Caeseele, H Smadi, D Haldane, G Zahariadis, K Mead, L Steven, L Strudwick, A Li, M Mulvey, I Martin

In-person learning low risk for COVID-19 acquisition: Findings from a population-based analysis of the 2020–2021 school year in Saskatchewan, Canada
M Trecker, L McLean, S Konrad, D Yalamanchili, K Langhorst, M Anderson